Forward Citations = 52

Loading Chart...

7 inventors (with patents filed for the assignee):

Carl R Merril (4 out of 28 patents)

Bruce M Cameron, Sr (3 out of 4 patents)

Dale VanderPutten (3 out of 3 patents)

4. Guy J Creed (3 out of 3 patents)

5. Richard E Warrington (1 out of 4 patents)

6. Abbas A Khan (1 out of 1 patent)

7. Jacinto J De La Parra (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 5844097 - Methods for the diagnosis of peripheral nerve damage (1998-12-01),

2. 5583201 - Methods for diagnosis of peripheral nerve damage (1996-12-10),

3. 5364793 - Methods for the diagnosis of peripheral nerve damage (1994-11-15),

4. 4940659 - Screening extra-cellular body fluids for superoxide dismutase (SOD-1) (1990-07-10),

5. 4782077 - Taliscanin and other aristolactams for treating neurological disorders, (1988-11-01),

Company Overview

Monoclonetics International, Inc. is a leading biotechnology company specializing in the development of monoclonal antibodies for various medical applications. With a team of experienced scientists and state-of-the-art facilities, we are dedicated to creating innovative solutions for the treatment of diseases. Our mission is to improve patient outcomes and make a positive impact on global health.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#844 in Houston, TX

#3,330 in Texas

#51,570 in US

Houston, TX, United States of America

Monoclonetics International, Inc.

Forward Citations = 52

7 inventors:

Carl R Merril (4 out of 28 patents)

Bruce M Cameron, Sr (3 out of 4 patents)

Dale VanderPutten (3 out of 3 patents)

4. Guy J Creed (3 out of 3 patents)

5. Richard E Warrington (1 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Monoclonetics International, Inc.. Retrieved from https://idiyas.com/company/monoclonetics-international

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Please report any incorrect information to [email protected]